Survival Status and Predictors Among Women with Advanced Stage of Cervical Cancer

References

• Sung H, Ferlay J, Siegel RL. et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Gopu1 U on systemic therapy for cervical cancer P, Febin Antony1, Sunu Cyriac2 KK& AMOD. Updates on systemic therapy for cervical cancer. JIndian J Med Res; 2022:293–302. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23144490. Accessed April 2, 2024.
   Google Scholar
• Derbie A, Mekonnen D, Nibret E, Misgan E, Maier M. Cervical cancer in Ethiopia: a review of the literature. Cancer Causes Control. 2023;34(1):1–11. doi:10.1007/s10552-022-01638-y
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global cancer observatory Ethiopia fact Sheet. Int Agency Res Cancer. 2021;133:2020–2021.
   Google Scholar
• Dickey BL, Coghill AE, Ellsworth GB, Wilkin TJ, Villa LL, Giuliano AR. An updated systematic review of human papillomavirus genotype distribution by cervical disease grade in women living with human immunodeficiency virus highlights limited findings from latin America. Sex Transm Dis. 2021;48(12):e248–54. doi:10.1097/OLQ.0000000000001412
   PubMed Web of Science ®Google Scholar
• Ferlay J, Colombet M, Soerjomataram I, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int, J, Cancer. 2019;144(8):1941–1953. doi:10.1002/ijc.31937
   PubMed Web of Science ®Google Scholar
• Sankaranarayanan R. Cancer survival in Africa, Asia, the Caribbean and Central America. Introduction. IARC Sci Publ. 2011;162:1–5.
   Google Scholar
• Drokow EK, Fangninou FF, Effah CY, et al. Cervical cancer survival times in Africa. Front Public Health. 2022;3:10.
   Google Scholar
• Bhatla N, Aoki D, Sharma DN, Sankaranarayanan R. Cancer of the cervix uteri: 2021 update. Int J Gynecol Obstet. 2021;155(S1):28–44. doi:10.1002/ijgo.13865
   PubMedGoogle Scholar
• Oaknin A, Rubio MJ, Redondo A, et al. SEOM guidelines for cervical cancer. Clin Transl Oncol. 2015;17(12):1036–1042. doi:10.1007/s12094-015-1452-2
   PubMed Web of Science ®Google Scholar
• Clark TG, Bradburn MJ, Love SB, Altman DG. Survival Analysis Part I: basic concepts and first analyses. Br J Cancer. 2003;89(2):232–238. doi:10.1038/sj.bjc.6601118
   PubMed Web of Science ®Google Scholar
• Corporation IBM. IBM SPSS Statistics Version 29; 2023.
   Google Scholar
• Griesel M, Parkin D, Thomssen C, Kantelhardt E. Cervical Cancer in Sub-Saharan Africa – a multinational population-based study on treatment guideline adherence. In: Kongressabstracts zur 13 Jahrestagung der Mitteldeutschen Gesellschaft für Frauenheilkunde und Geburtshilfe eV (MGFG). Georg Thieme Verlag KG; 2019.
   Google Scholar
• Wabinga H, Ramanakumar AV, Banura C, Luwaga A, Nambooze S, Parkin DM. Survival of cervix cancer patients in Kampala, Uganda: 1995–1997. Br J Cancer. 2003;89(1):65–69. doi:10.1038/sj.bjc.6601034
   PubMed Web of Science ®Google Scholar
• Kantelhardt EJ, Moelle U, Begoihn M, et al. Cervical Cancer in Ethiopia: survival of 1059 Patients Who Received Oncologic Therapy. Oncologist. 2014;19(7):727–734. doi:10.1634/theoncologist.2013-0326
   PubMed Web of Science ®Google Scholar
• Wassie M, Argaw Z, Tsige Y, Abebe M, Kisa S. Survival status and associated factors of death among cervical cancer patients attending at Tikur Anbesa Specialized Hospital, Addis Ababa, Ethiopia: a retrospective cohort study. BMC Cancer. 2019;19(1):1. doi:10.1186/s12885-019-6447-x
   PubMed Web of Science ®Google Scholar
• Chokunonga E, Ramanakumar AV, Nyakabau AM, et al. Survival of cervix cancer patients in Harare, Zimbabwe, 1995–1997. International Journal of Cancer. 2004;109(2):274–277. doi:10.1002/ijc.11670
   PubMed Web of Science ®Google Scholar
• Do Carmo CC, Luiz RR. Survival of a cohort of women with cervical cancer diagnosed in a Brazilian cancer center. Rev Saude Publica. 2011;45(4):661–667. doi:10.1590/S0034-89102011005000029
   PubMed Web of Science ®Google Scholar
• Wenzel HHB, Bekkers RLM, Lemmens VEPP, Van der Aa MA, Nijman HW. No improvement in survival of older women with cervical cancer—A nationwide study. Eur J Cancer. 2021;151:159–167. doi:10.1016/j.ejca.2021.04.014
   PubMed Web of Science ®Google Scholar
• Vishma B, Prakash B, Kulkarni P, Renuka M. Survival and prognostic factors for cervical cancer: a hospital based study in Mysuru, India. Int J Community Med Public Heal. 2016;218:23.
   Google Scholar
• Maranga IO, Hampson L, Oliver AW, et al. Analysis of factors contributing to the low survival of cervical cancer patients undergoing radiotherapy in Kenya. PLoS One. 2013;8(10):10. doi:10.1371/journal.pone.0078411
   Web of Science ®Google Scholar
• Chokunonga E, Ramanakumar AV, Nyakabau AM, et al. Survival of cervix cancer patients in Harare, Zimbabwe, 1995–1997. Int J Cancer. 2004;109(2):274–277. doi:10.1002/ijc.11670
   PubMed Web of Science ®Google Scholar
• Thulaseedharan JV, Malila N, Swaminathan R, et al. Survival of Patients With Cervical Cancer in Rural India. J Clin Gynecol Obstet. 2015;4(4):290–296. doi:10.14740/jcgo367w
   Google Scholar
• Carneiro SR, De Araújo Fagundes M, Neves LMT, Da Silva Souza G, Da Conceição Nascimento Pinheiro M. Five-year survival and associated factors in women treated for cervical cancer at a reference hospital in the Brazilian Amazon. PLoS One. 2017;12(11):1–11. doi:10.1371/journal.pone.0187579
   Web of Science ®Google Scholar
• Seifu B, Fikru C, Yilma D, Tessema F, Brody JP. Predictors of time to death among cervical cancer patients at Tikur Anbesa specialized hospital from 2014 to 2019: a survival analysis. PLoS One. 2022;17(2 February):1–15. doi:10.1371/journal.pone.0264369
   Web of Science ®Google Scholar
• Jayant K, Sankaranarayanan R, Thorat RV, et al. Improved survival of cervical cancer patients in a screened population in rural India. Asian Pacific J Cancer Prev. 2016;17(11):4837–4844.
   PubMedGoogle Scholar
• Khamis SI, Mrema AS, Katanga J, Lugina EL. Survival in Cervical Cancer and Its Predictors at Ocean Road Cancer Institute From January to December 2012. JCO Glob Oncol. 2021;7(7):734–739. doi:10.1200/GO.20.00616
   PubMedGoogle Scholar
• Cancer Council Australia. Understanding Cervical Cancer; 2019:4–68. Available from: https://www.cancer.org.au/assets/pdf/understanding-cervical-cancer-booklet. Accessed April 2, 2024.
   Google Scholar
• Tekalign T, Teshome M, Ekwunife OI. Prevalence and determinants of late-stage presentation among cervical cancer patients, a systematic review and meta-analysis. PLoS One. 2022;17(4):1–13. doi:10.1371/journal.pone.0267571
   Web of Science ®Google Scholar
• Begoihn M, Mathewos A, Aynalem A, et al. Cervical cancer in Ethiopia-predictors of advanced stage and prolonged time to diagnosis. Infect Agent Cancer. 2019;14(1):1–7. doi:10.1186/s13027-019-0255-4
   PubMed Web of Science ®Google Scholar
• Mattern J, Letendre I, Sibiude J, et al. Diagnosis of advanced cervical cancer, missed opportunities? BMC Womens Health. 2022;22(1):1–6. doi:10.1186/s12905-022-01668-3
   PubMed Web of Science ®Google Scholar
• Musa J, Nankat J, Achenbach CJ, et al. Cervical cancer survival in a resource-limited setting-North Central Nigeria. Infect Agent Cancer. 2016;11(1):0–7. doi:10.1186/s13027-016-0062-0
   Google Scholar
• Dereje N, Addissie A, Worku A, et al. Association between waiting time for radiotherapy initiation and disease progression among women with cervical cancer in Addis Ababa, Ethiopia. Int J Cancer. 2021;149(6):1284–1289. doi:10.1002/ijc.33689
   PubMed Web of Science ®Google Scholar
• Koh WJ, Abu-Rustum NR, Bean S, et al. Cervical cancer, version 3.2019. JNCCN J Natl Compr Cancer Netw. 2019;17(1):64–84. doi:10.6004/jnccn.2019.0001
   PubMed Web of Science ®Google Scholar
• Marth C, Landoni F, Mahner S, McCormack M, Gonzalez-Martin A, Colombo N. Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017;28(Supplement 4):iv72–83. doi:10.1093/annonc/mdx220
   PubMedGoogle Scholar
• Ababa A, Kantelhardt EJ, Assefa M Association between waiting time for radiotherapy initiation and disease progression among women with cervical cancer in; 2021:1284–1289.
   Google Scholar
• Tsai CH, Kung PT, Kuo WY, Tsai WC. Effect of time interval from diagnosis to treatment for non-small cell lung cancer on survival: a national cohort study in Taiwan. BMJ Open. 2020;10(4):1–15. doi:10.1136/bmjopen-2019-034351
   Web of Science ®Google Scholar
• Ramey SJ, Asher D, Kwon D, et al. Delays in definitive cervical cancer treatment: an analysis of disparities and overall survival impact. Gynecol Oncol. 2018;149(1):53–62. doi:10.1016/j.ygyno.2017.12.010
   PubMed Web of Science ®Google Scholar
• Gizaw M, Addissie A, Getachew S, et al. Cervical cancer patients presentation and survival in the only oncology referral hospital, Ethiopia: a retrospective cohort study. Infect Agent Cancer. 2017;12(1):1–7. doi:10.1186/s13027-017-0171-4
   PubMedGoogle Scholar
• Fyles AW, Milosevic M, Pintilie M, Syed A, Hill RP. Anemia, hypoxia and transfusion in patients with cervix cancer: a review. Radiother Oncol. 2000;57(1):13–19. doi:10.1016/S0167-8140(00)00245-0
   PubMed Web of Science ®Google Scholar
• Wassie M, Aemro A, Fentie B, Khatami F. Prevalence and associated factors of baseline anemia among cervical cancer patients in Tikur Anbesa Specialized Hospital, Ethiopia. BMC Womens Health. 2021;21(1):1–8. doi:10.1186/s12905-020-01152-w
   PubMed Web of Science ®Google Scholar
• Kigula-Mugambe JB, Kavuma A. Effect of HIV serological status on outcome in patients with cancer of cervix treated with radiotherapy. East Afr Med J. 2006;83(8):416–423. doi:10.4314/eamj.v83i8.9455
   PubMedGoogle Scholar
• Wu ES, Urban RR, Krantz EM, et al. The association between HIV infection and cervical cancer presentation and survival in Uganda. Gynecol Oncol Reports. 2020;31:100516. doi:10.1016/j.gore.2019.100516
   PubMed Web of Science ®Google Scholar
• Leitao MM, White P, Cracchiolo B. Cervical cancer in patients infected with the human immunodeficiency virus. Cancer. 2008;112(12):2683–2689. doi:10.1002/cncr.23504
   PubMed Web of Science ®Google Scholar
• Palefsky JM, Minkoff H, Kalish LA, et al. Cervicovaginal Human Papillomavirus Infection in. J Natl Cancer Inst. 1999;91(3):226–236. doi:10.1093/jnci/91.3.226
   PubMedGoogle Scholar
• Dryden-Peterson S, Bvochora-Nsingo M, Suneja G, et al. HIV infection and survival among women with cervical cancer. J Clin Oncol. 2016;34(31):3749–3757. doi:10.1200/JCO.2016.67.9613
   PubMed Web of Science ®Google Scholar
• Burt LM, McCormak M, Lecuru F, et al. Cervix Cancer in Sub-Saharan Africa: An Assessment of Cervical Cancer Management. JCO Global Oncology. 2021;7:173–182. doi: 10.1200/go.20.00079
   PubMedGoogle Scholar
• Sankaranarayanan R, Budukh AM, Rajkumar R. Effective screening programmes for cervical cancer in low- and middle-income developing countries. Bulletin of the World Health Organization. 2001;79(10):954–962. doi: 10.1590/S0042
   PubMed Web of Science ®Google Scholar